A Closer Look at 5 Analyst Recommendations For OptimizeRx
A Closer Look at 5 Analyst Recommendations For OptimizeRx
分析师给Optimizerx的5个建议深入研究
A clear picture of OptimizeRx's perception among financial experts...In the latest quarter, 5 analysts provided ratings for OptimizeRx (NASDAQ:OPRX), showcasing a mix of bullish and bearish perspectives.
在最新的季度里，5位分析师对OptimizeRx（纳斯达克股票代码：OPRX）提供了评级，展示了看好和看淡的观点。
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
以下表格概括了他们最近的评级，展示了过去30天内的情绪演变并与之前的几个月进行了比较。
Analysts have recently evaluated OptimizeRx and provided 12-month price targets. The average target is $14.4, accompanied by a high estimate of $16.00 and a low estimate of $11.00. A decline of 4.0% from the prior average price target is evident in the current average.
分析师最近评估了OptimizeRx并提供了12个月的目标价。平均目标价为14.4美元，伴随着16.0美元的高估价和11.0美元的低估价。当前平均价格目标较前期下降了4.0%。
Investigating Analyst Ratings: An Elaborate Study
分析师评级的调查：一项详尽的研究
A clear picture of OptimizeRx's perception among financial experts...
通过对近期分析师行为...
登录免费看全文
登录/注册
资讯热榜
更新时间